The burden of cardiovascular diseases in Vietnam is growing rapidly, with acutecoronary syndrome (ACS) becoming one of the leading causes of hospitalization and death. According to the World Health Organization (WHO), cardiovascular diseases accounted for nearly 70% of non-communicable disease deaths in Vietnam as of 2016, highlighting an urgency need for improved treatment pathways and enhanced skills for frontline medical staff.
 |
|
Sanofi Aventis Vietnam and Terumo Vietnam’s representatives at the signing ceremony. Photo courtesy of Terumo Vietnam |
Recognizing to this challenge, Terumo Vietnam and Sanofi-Aventis Vietnam, two healthcare leaders committed to advancing medical science and improving patient outcomes, have teamed up to address training gaps and support the ongoing professional development of interventional cardiologists nationwide. Central to this partnership is the launch of the PCI (Percutaneous Coronary Intervention) Roadshow series, a comprehensive training initiative. Scheduled over the next two years, this series will deliver five intensive workshops throughout Vietnam.
Each PCI workshop will feature state-of-the-art case-based learning, hands-on practice with advanced simulation models, expert-led discussions on ACS management strategies, and the latest insights into PCI techniques and medical device innovations.
This program aims not only to update physicians on evolving guidelines and best practices but also to foster peer-to-peer learning and regional collaboration within Vietnam’s cardiovascular community.
Nguyen Do Bao Chau, General Director of Terumo Vietnam, emphasized the importance of physician training in enhancing the overall healthcare system “By investing in the development of healthcare professionals, we contribute directly to a stronger system that can swiftly and effectively respond to patients’ need”, she said. “This partnership reaffirms our long-term commitment to contributing to society through healthcare.”
 |
|
Both companies’ representative took photo at the ceremony. Photo courtesy of Terumo Vietnam |
Didier Martin, Head of Pharma at Sanofi-Aventis Vietnam, highlighted the value of strategic alliances in healthcare innovation. “At Sanofi, we believe collaboration is crucial for driving innovation and improving patient outcomes. Cardiovascular care is an area where Sanofi has a strong legacy. With Terumo’s advanced medical technologies, we aim to create a platform that significantly enhances the knowledge and skills of interventional cardiologists, ultimately benefiting patients across Vietnam,” he noted.
With the inaugural workshop planned for mid-2025, both companies are optimistic about the program’s positive impact. Beyond the immediate educational initiatives, this partnership lays the foundation for future collaborative efforts in clinical education, research, and patient care.
 |
|
The two companies discussing about strategic partnership. Photo courtesy of Terumo Vietnam |
Terumo, headquartered in Tokyo, is a global leader in medical technology with a century-long commitment to “Contributing to Society through Healthcare.” Operating in over 160 countries and regions, Terumo provides innovative solutions ranging from vascular intervention and cardiovascular surgical products to blood transfusion and cell therapy technologies, as well as essential clinical products for daily practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments.
Sanofi is an innovative global healthcare company present in more than 70 countries, with over 70 years of history in Vietnam. Guided by the vision of “Chasing the miracles of science to improve people’s lives,” Sanofi recently announced a strategic direction reaffirming its goal to become a leader in immunology and the first biopharma company powered by AI at scale.
